Sign up for a free trial now
  • Login
  • Subscribe
  • Take a FREE Trial
  • About Us
  • Contact us
  • RSS

21 May 2013


The Pharma Letter
  • Home
  • 7 Day Premium Trial
  • Pharmaceuticals
  • Biotechnology
  • Generics
  • Events
  • Companies
  • Drugs
  • Subscribe

Isradipine Articles

Isradipine slows Parkinson's disease

25 June 2007

Actavis launches five new products in USA

17 July 2006

Amylin to co-promote Reliant cardiovasculars

19 April 2004

Update: Alkermes to acquire Reliant in $934M deal

1 April 2002

Alkermes to acquire Reliant in $934M deal

25 March 2002

MIDAS Trial Reopens Ca Channel Blocker Debate

16 September 1996

JAMA Study Ups Debate Over Calcium Blockers

4 September 1995

DYNACIRC TO BE MARKETED BY SANDOZ

25 July 1994

ACTISITE CLEARED FOR MARKET IN USA

11 April 1994

PHARMA SALES DRIVE SANDOZ IN 1993

31 January 1994

FDA YEAR-END APPROVALS FOR 1993

10 January 1994

SUSTAINABLE EARNINGS GROWTH FOR SANDOZ

16 August 1993

SANDOZ POSTS STRONG NET INCOME

26 July 1993

ALZA AND SANDOZ FILE NDA

25 January 1993

SANDOZ PHARMA DIV 1991 PROGRESS

25 May 1992

US NEW PRESCRIPTI0N DRUG SALES IN 1991

13 April 1992

SANDOZ LAUNCHES ICAZ LP IN FRANCE

9 March 1992

Showing 1-17 of 17 articles

Go to beginningPrevious
  • 1
NextGo to end
  • Hot Topics
  • Most Read
  • Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
  • Elan makes "transformational" acquisitions and a divestment
  • HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
  • CIS countries prepare for the introduction of drug reimbursement schemes
  • Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law
  • Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
  • Elan makes "transformational" acquisitions and a divestment
  • HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
  • CIS countries prepare for the introduction of drug reimbursement schemes
  • Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law

30 Day Premium Trial


Events

Twitter Right banner

RSS



© 2013 thepharmaletter.com

  • Home
  • RSS
  • About Us
  • Subscribe
  • Terms and Conditions
  • Article Archive
Site powered by WORKSsitebuilder CMS